Friday, November 22, 2024

FINEARTS-HF Study

Finerenone Meets Primary Endpoint in Phase III Study

Finerenone Meets Primary Endpoint in a Phase III cardiovascular outcomes study, Bayer recently announced the positive results from its Phase III FINEARTS-HF study, which evaluated the efficacy and safety of finerenone in patients with heart failure with mildly reduced...

Latest News

EDEKA Gross-Zimmern E Center Reopens with Modern Upgrades

The EDEKA Gross-Zimmern (Groß-Zimmern) E Center has reopened at Rontgenstrasse (Röntgenstraße) 3 after a comprehensive renovation. Store manager Dominik...